1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. DBV Technologies
  6. News
  7. Summary
    DBV   FR0010417345

DBV TECHNOLOGIES

(DBV)
  Report
Real-time Euronext Paris  -  05/27 11:35:20 am EDT
2.910 EUR   +4.00%
05/27European ADRs Move Higher in Friday Trading
MT
05/25European ADRs Move Lower in Wednesday Trading
MT
05/20European ADRs Move Sharply Higher in Friday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Rising Wednesday

12/22/2021 | 12:14pm EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
ACHILLES CORPORATION 0.76% 1328 Delayed Quote.6.33%
ACHILLES THERAPEUTICS PLC 3.23% 2.56 Delayed Quote.-48.90%
BHP GROUP LIMITED 2.46% 43.67 Delayed Quote.5.23%
BIOFRONTERA AG 0.90% 1.125 Delayed Quote.-23.99%
BIONTECH SE 5.57% 166.96 Delayed Quote.-35.24%
BRITISH AMERICAN TOBACCO PLC -0.39% 3550.5 Delayed Quote.29.89%
DBV TECHNOLOGIES 4.00% 2.91 Real-time Quote.-4.87%
GENENTA SCIENCE S.P.A. 9.56% 8.25 Delayed Quote.-24.74%
INTERCONTINENTAL HOTELS GROUP PLC 1.03% 4921 Delayed Quote.3.24%
MEREO BIOPHARMA GROUP PLC 8.77% 0.521 Delayed Quote.-67.44%
MORPHOSYS AG 0.65% 20.16 Delayed Quote.-39.55%
ORPHAZYME A/S -5.84% 1.29 Delayed Quote.-92.48%
SPARK NETWORKS SE 4.73% 1.9899 Delayed Quote.-36.63%
TRINITY BIOTECH PLC 0.00% 1.38 Delayed Quote.-3.50%
VACCITECH PLC -1.83% 4.3 Delayed Quote.-61.30%
VERONA PHARMA PLC 0.45% 4.48 Delayed Quote.-33.33%
ZEALAND PHARMA A/S 1.98% 92.5 Delayed Quote.-36.25%
All news about DBV TECHNOLOGIES
05/27European ADRs Move Higher in Friday Trading
MT
05/25European ADRs Move Lower in Wednesday Trading
MT
05/20European ADRs Move Sharply Higher in Friday Trading
MT
05/18European ADRs Move Lower in Wednesday Trading
MT
05/16DBV TECHNOLOGIES S.A. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/13European ADRs Move Higher in Friday Trading
MT
05/12DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeti..
GL
05/12DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeti..
AQ
05/12European ADRs Decline in Thursday Trading
MT
05/10Goldman Sachs Downgrades DBV Technologies to Neutral From Buy
MT
More news
Analyst Recommendations on DBV TECHNOLOGIES
More recommendations
Financials
Sales 2022 4,73 M 5,06 M 5,06 M
Net income 2022 -72,9 M -78,1 M -78,1 M
Net cash 2022 83,2 M 89,2 M 89,2 M
P/E ratio 2022 -2,49x
Yield 2022 -
Capitalization 177 M 190 M 190 M
EV / Sales 2022 19,9x
EV / Sales 2023 21,0x
Nbr of Employees 88
Free-Float 91,7%
Chart DBV TECHNOLOGIES
Duration : Period :
DBV Technologies Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DBV TECHNOLOGIES
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 2,91 €
Average target price 5,53 €
Spread / Average Target 89,9%
EPS Revisions
Managers and Directors
Daniel Tassé Chief Executive Officer & Executive Director
Sébastien Robitaille Chief Financial Officer
Michel de Rosen Non-Executive Chairman
Pharis Mohideen Chief Medical Officer
Pascal Wotling Chief Technical Operations Officer
Sector and Competitors
1st jan.Capi. (M$)
DBV TECHNOLOGIES-4.87%190
MERCK KGAA-21.50%83 006
KYOWA KIRIN CO. LTD.-12.92%11 543
SK BIOPHARMACEUTICALS CO., LTD.-9.77%5 492
YUHAN CORPORATION-3.70%3 252
INDIVIOR PLC25.37%2 855